Bone Formation, Growth, and Repair

M. T. Collins; C. A. Stratakis

doi:10.1055/s-0042-119907

Hormone and Metabolic Research, Table of Contents

Horm Metab Res 2016; 48(11): 687-688
DOI: 10.1055/s-0042-119907

Editorial

Bone Formation, Growth, and Repair

M. T. Collins

¹Section on Skeletal Diseases and Mineral Homeostasis, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA

,

C. A. Stratakis

²Section on Endocrinology & Genetics, Eunice Kennedy Shriver National Institute of Child Health & Human Development, National Institutes of Health, Bethesda, MD, USA

› Author Affiliations

Abstract

Full Text

References

References
1 Hsiao EC, Millard SM, Nissenson RA. Gs/Gi regulation of bone cell differentiation: review and insights from engineered receptors. Horm Metab Res 2016; 48: 689-699
2 Polymeri A, Giannobile WV, Kaigler D. Bone marrow stromal stem cells in tissue engineering and regenerative medicine. Horm Metab Res 2016; 48: 700-713
3 Liu S, Shapiro JM, Saloustros E, Stratakis CA. Bone abnormalities in mice with protein kinase A (PKA) defects reveal a role of cyclic AMP signaling in bone stromal cell-dependent tumor development. Horm Metab Res 2016; 48: 714-725
4 Shapiro JM, Oyen ML. Engineering approaches for understanding osteogenesis: hydrogels as synthetic bone microenvironments. Horm Metab Res 2016; 48: 726-736
5 Nilsson O, Isoherranen N, Guo MH, Lui JC, Jee YH, Guttmann-Bauman I, Acerini C, Lee W, Allikmets R, Yanovski JA, Dauber A, Baron J. Accelerated skeletal maturation in disorders of retinoic acid metabolism: a case report and focused review of the literature. Horm Metab Res 2016; 48: 737-744
6 Taylan F, Mäkitie O. Abnormal proteoglycan synthesis due to gene defects causes skeletal diseases with overlapping phenotypes. Horm Metab Res 2016; 48: 745-754
7 Komori T. Glucocorticoid signaling and bone biology. Horm Metab Res 2016; 48: 755-763
8 Tack LJ, Tatsi C, Stratakis CA, Lodish MB. Effects of glucocorticoids on bone: what we can learn from pediatric endogenous Cushing’s syndrome. Horm Metab Res 2016; 48: 764-770
9 Dhaliwal R, Rosen CJ. Type 2 diabetes and aging: a not so sweet scenario for bone. Horm Metab Res 2016; 48: 771-778
10 Jha S, Blau JE, Bhattacharyya T. Normal and delayed fracture healing: symphony and cacophony. Horm Metab Res 2016; 48: 779-784
11 Sacchetti B, Funari A, Michienzi S, Di Cesare S, Piersanti S, Saggio I, Tagliafico E, Ferrari S, Robey PG, Riminucci M, Bianco P. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 2007; 131: 324-336
12 Bianco P, Riminucci M, Gronthos S, Robey PG. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 2001; 19: 180-192
13 Bianco P, Robey PG. Skeletal stem cells. Development 2015; 142: 1023-1027
14 Georgiadis M, Müller R, Schneider P. Techniques to assess bone ultrastructure organization: orientation and arrangement of mineralized collagen fibrils. J R Soc Interface 2016; 13
15 Adamczyk P, Bužga M, Holéczy P, Švagera Z, Zonča P, Sievänen H, Pluskiewicz W. Body size, bone mineral density, and body composition in obese women after laparoscopic sleeve gastrectomy: a 1-year longitudinal study. Horm Metab Res 2015; 47: 873-879
16 Bo T, Zhu JM. Low levels of free testosterone correlated with bone mineral densities of femoral necks in aged healthy Shanghainese men. Horm Metab Res 2014; 46: 697-701
17 Dumic-Cule I, Draca N, Luetic AT, Jezek D, Rogic D, Grgurevic L, Vukicevic S. TSH prevents bone resorption and with calcitriol synergistically stimulates bone formation in rats with low levels of calciotropic. Horm Metab Res 2014; 46: 305-312
18 de Albuquerque Maia L, Lisboa PC, de Oliveira E, da Conceição EP, Lima IC, Lopes RT, Ruffoni LD, Nonaka KO, de Moura EG. Bone structure and strength are enhanced in rats programmed by early overfeeding. Horm Metab Res 2014; 46: 259-268
19 Anastasilakis AD, Polyzos SA, Makras P, Savvides M, Sakellariou GT, Gkiomisi A, Papatheodorou A, Terpos E. Circulating periostin levels do not differ between postmenopausal women with normal and low bone mass and are not affected by zoledronic acid treatment. Horm Metab Res 2014; 46: 145-149
20 Kangas L, Härkönen P, Väänänen K, Peng Z. Effects of the selective estrogen receptor modulator ospemifene on bone in rats. Horm Metab Res 2014; 46: 27-35